Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

434

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Community-Acquired InfectionsBacterial PneumoniaCross Infection
Interventions
DRUG

Tigecycline

DRUG

Levofloxacin

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00081575 - Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia | Biotech Hunter | Biotech Hunter